Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

Université Laval

$70,000.00

Métabolisme des estrogènes chez la femme et cancers hormonaux-dépendants

FY 2008-09

Summary
Steroid hormones, including estrogens (estradiol and estrone), are key determinants in the etiology of breast and endometrial cancer, which are mainly hormone-dependant sickness. They occur predominantly in post-menopausal women who lack estrogen production by ovaries. New results trend to demonstrate that target tissues contain all the enzymes necessary for the synthesis and metabolism of estrogens. Our first hypothesis is that unbalanced between the metabolism pathways of estrogens may lead to the formation of pro-carcinogen or of protector metabolites, therefore influencing the malignant transformation. Secondly, we think that the presence of tumor may be perceptible through plasmatic hormones, and that shifts between the three main estrogens metabolism pathway, following 2-, 4- or 16- hydroxylation, may be detectable. Finally, by establishing the estrogens metabolic profile in healthy post-menopausal women, compared to women with breast or endometrial cancer, it may be possible to discover biomarker of predisposition to hormonal-dependant cancer or to detect early the presence of malignant cells. In my doctoral studies, I want to characterize the complete profile of the enzymes implicated in the synthesis/metabolism of estrogens. In cell lines and primary cultured cells, the impacts of the different estrogens metabolites will be tested, in order to understand their different actions. Finally, the plasmatic hormonal profile will be achieved, in order to determine a biomarker predictive of cancer or of the predisposition to hormonal-dependant cancer.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
184389
Name
Audet-Walsh Étienne
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Métabolisme des estrogènes chez la femme et cancers hormonaux-dépendants
Programtype2
Studentship Programs
Orgnameinp2
Université Laval
Cihramount2
$70,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Cancer; Cancers Hormonaux-Dépendants; Endomètre; Estrogènes; Profil Hormonal; Sein
Abstract
Steroid hormones, including estrogens (estradiol and estrone), are key determinants in the etiology of breast and endometrial cancer, which are mainly hormone-dependant sickness. They occur predominantly in post-menopausal women who lack estrogen production by ovaries. New results trend to demonstrate that target tissues contain all the enzymes necessary for the synthesis and metabolism of estrogens. Our first hypothesis is that unbalanced between the metabolism pathways of estrogens may lead to the formation of pro-carcinogen or of protector metabolites, therefore influencing the malignant transformation. Secondly, we think that the presence of tumor may be perceptible through plasmatic hormones, and that shifts between the three main estrogens metabolism pathway, following 2-, 4- or 16- hydroxylation, may be detectable. Finally, by establishing the estrogens metabolic profile in healthy post-menopausal women, compared to women with breast or endometrial cancer, it may be possible to discover biomarker of predisposition to hormonal-dependant cancer or to detect early the presence of malignant cells. In my doctoral studies, I want to characterize the complete profile of the enzymes implicated in the synthesis/metabolism of estrogens. In cell lines and primary cultured cells, the impacts of the different estrogens metabolites will be tested, in order to understand their different actions. Finally, the plasmatic hormonal profile will be achieved, in order to determine a biomarker predictive of cancer or of the predisposition to hormonal-dependant cancer.
Competitiondate
200810
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Audet-Walsh, Étienne
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $70,000~ $0~